Unknown

Dataset Information

Precision medicine to prevent glaucoma-related blindness.


ABSTRACT:

Purpose of review

Approximately 10% of patients become blind despite using evidence-based guidelines developed from clinical trials and epidemiology studies. Our purpose is to review opportunities to decrease glaucoma-related blindness using the emerging principles of precision medicine.

Recent findings

The current review focuses on three topics: first, candidate biomarkers for angle-based surgeries, second, head-mounted display (HMD) technology for vision and testing, and third, glaucoma risk alleles discovered by genome-wide association studies. First, in angle-based surgeries, tracers injected into the anterior chamber or Schlemm's canal have allowed visualization of aqueous veins. We describe an innovative use of optical coherence tomography angiography to visualize aque

SUBMITTER: Moroi SE 

PROVIDER: S-EPMC6913095 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature